Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Allergicentrum Malmö AB
AB
Active
Org 5594331018
Rådmansgatan 14
Medical specialists activities · NACE 8622
Est. 2023
0 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
SEK 0
EBITDA margin
—
Equity ratio
76.0%
Financial strength
Net profit 2024
SEK -20K
0 employees
EBITDA — year on year
SEK millions
0M
-0M
-1M
-1M
-1M
0M
2023
0M
0%
2024
Key figures
Annual report 2024
Revenue
SEK 0
—
EBITDA
SEK -20K
—
Net profit
SEK -20K
—
Total assets
SEK 25K
+0%
Equity
SEK 19K
-24%
Employees
0
—
Company information
Legal name
Allergicentrum Malmö AB
Org number
5594331018
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
8 maj 2023
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-11-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas ensam av Papapostolou, Georgia
Company purpose
Bolaget ska bedriva digital allergimottagningsverksamhet.
Contact
Address
Rådmansgatan 14
Email
gp@leuko3ena.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Medical specialists activities
Companies in Malmö
All Sweden companies
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2023
0M
2024
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2023
0M
2024
Income statement
SEK thousands
Item
2023
2024
Revenue
0
0
Staff expenses
—
—
EBITDA
—
−20
Depreciation & amort.
—
—
EBIT
0
−20
Net financials
—
—
Profit before tax
0
−20
Tax
—
—
Net profit
—
−20
Balance sheet
SEK thousands
Item
2023
2024
Total assets
25
25
Equity
25
19
Long-term debt
—
—
Short-term debt
—
6
Total debt
—
6
Financial ratios
5-year trend
EBITDA margin
-2037500.0%
This company
15.8%
Market median
-12895670% vs market
2023
2024
Equity ratio
76.0%
This company
38.2%
Market median
+99% vs market
2023
2024
Return on equity
-107.2%
This company
18.4%
Market median
-683% vs market
2023
2024
Net profit margin
-2037500.0%
This company
8.1%
Market median
-25154421% vs market
2023
2024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2023
2024
Debt / equity
0.32×
This company
0.62×
Market median
+48% vs market
2023
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-12-01 – 2024-11-30
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-05-08 – 2023-11-30
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
GP
Georgia Papapostolou
Chief Executive Officer
Chief Executive Officer
2023
Board of directors
Non-executive oversight
Name
Role
Member since
Current (1)
NP
Niki Papapostolou
Deputy Board Member
2023
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Leuko3ena AB
Company
100%
100%
2025
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
Leuko3ena AB
Allergicentrum Malmö AB
(this company)
Board network connections
Board members of Allergicentrum Malmö AB also hold positions in
0
other companies.
Person
Role here
Other companies
Georgia Papapostolou
Chief Executive Officer
0 companies
Niki Papapostolou
Deputy Board Member
0 companies